Evommune (EVMN) Non-Current Assets (2024 - 2026)

Evommune (EVMN) has 3 years of Non-Current Assets data on file, last reported at $106.6 million in Q1 2026.

• On a quarterly basis, Non-Current Assets changed N/A year-over-year to $106.6 million in Q1 2026; TTM through Mar 2026 was $182.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $71.5 million, up 3357.57% from the prior year.
• Non-Current Assets for Q1 2026 stood at $106.6 million, up from $71.5 million in the prior quarter.
• Over the last five years, Non-Current Assets for EVMN reached as high as $106.6 million in Q1 2026 and fell as low as $2.1 million in Q4 2024.
• Historically, Non-Current Assets has averaged $45.7 million across 3 years, with a median of $37.0 million in 2025.
• On a YoY basis, Non-Current Assets climbed as much as 3357.57% in 2025 and fell as far as 3357.57% in 2025.
• Year by year, Non-Current Assets stood at $2.1 million in 2024, then jumped by 3357.57% to $71.5 million in 2025, then surged by 49.16% to $106.6 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $106.6 million in Q1 2026, $71.5 million in Q4 2025, and $2.6 million in Q3 2025.